On Tuesday, the FDA issued a warning regarding the dangers associated with counterfeit versions of AbbVie Inc’s (NYSE:ABBV) Botox used for cosmetic purposes.  The alert follows reports of adverse reactions among individuals who received injections of fake Botox across several states, prompting investigations by the FDA and the Centers for Disease Control and Prevention (CDC). Related: Botox And Similar Injections Have Associated Risks: Consumer Group Pushes for Stronger Warnings. Nineteen cases involving harmful reactions have been documented in nine states, including Colorado, Florida, Illinois, Kentucky, Nebraska, New Jersey, New York, Tennessee, and Washington.  These reactions occurred after individuals received injections of counterfeit Botox from unlicensed practitioners or in non-healthcare settings ...